Prognosis
Pfizer-BioNTech Covid Vaccine Wins Landmark U.S. Approval
- Clearance comes as delta-fueled wave of infections grips U.S.
- Milestone likely to lead to more mandates, increase confidence
This article is for subscribers only.
The Covid-19 vaccine made by Pfizer Inc. and BioNTech SE was granted a full approval by U.S. regulators, a milestone expected to help bolster the immunization drive amid a renewed surge in infections.
The Food and Drug Administration said in a statement on Monday that it had cleared the shot for the prevention of the disease caused by the novel coronavirus in people 16 and older. It will be marketed under the name Comirnaty.